Trial Oversight Spotlight #14: Ricky Lakhani
In this episode:
Ricky Lakhani discusses the integration of technology in clinical trials, focusing on the challenges posed by disconnected systems, the importance of timely data, and the need for collaboration among teams. Tom and Ricky emphasise the significance of quality by design and the necessity for organisations to adapt to new technologies while maintaining a balance between standardisation and flexibility.
The conversation also highlights the integration partnership recently announced by Mayet and PHARMASEAL, as a value driver for their clients.
Key points:
- Integration in clinical trials is essential for efficiency
- Disconnected systems lead to data silos and inefficiencies
- Timely data visibility is crucial for effective trial management
- Quality by design principles should guide clinical research
- Partnerships can enhance integration and data sharing
- Data duplication can significantly impact trial timelines
- A mindset shift towards data utilisation is necessary for progress
Time stamps:
- – Intro
- – Challenges of disconnected systems
- – Symptoms and root causes of data issues
- – Quality by design in clinical trials
- – Data utilisation challenges in clinical trials
- – Mayet x PHARMASEAL integration
- – Driving organisational change
Guest Bio
Ricky Lakhani
Chief Product Officer at PHARMASEAL
Ricky is a product management expert with 20 years of experience in life sciences and technology. He has led the development of innovative software solutions that improve clinical trial execution, holding key roles at Amgen, Roche, and Medidata. Known for bridging scientific rigor with technical strategy, Ricky has a strong track record of turning complex challenges into scalable, user-focused products.
His leadership has consistently driven product innovation, operational efficiency, and business growth across the clinical research landscape.
Host Bio
Tom is running the Trial Oversight Spotlight Interview Series where he meets with a variety of colleagues working in clinical research. They discuss a selection of the most important topics and decisions that are currently being navigated by all types of organisations delivering research.
Tom has spent over a decade in Clinical Trials Operations and Quality Assurance and has experienced the impact that suboptimal vendor oversight and vendor non-compliance can have on the quality of clinical trials. Mayet is the solution to fix this.